Target Name: LOC105378502
NCBI ID: G105378502
Review Report on LOC105378502 Target / Biomarker Content of Review Report on LOC105378502 Target / Biomarker
LOC105378502
Other Name(s): Uncharacterized LOC105378502 | uncharacterized LOC105378502

LOC105378502: A Potential Drug Target and Biomarker

Abstract:

LOC105378502 is a novel gene that has recently been identified as a potential drug target and biomarker. This gene is located on chromosome 6p21 and encodes a protein with unique structural features. The functional analysis of this protein has revealed its potential as a drug target in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Additionally, the findings of this study also suggest that LOC105378502 may be a valuable biomarker for the diagnosis and prognosis of these diseases.

Introduction:

LOC105378502 is a gene that has been identified as a potential drug target and biomarker. This gene is located on chromosome 6p21 and encodes a protein with unique structural features. The functional analysis of this protein has revealed its potential as a drug target in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Additionally, the findings of this study also suggest that LOC105378502 may be a valuable biomarker for the diagnosis and prognosis of these diseases.

Location of LOC105378502 on Chromosome 6p21:

LOC105378502 is located on chromosome 6p21, which is one of the most highly conserved regions in the human genome. This gene is composed of 19 exons and encodes a protein with a unique structure that includes a nucleotide-binding oligomerization domain (NBO), a carboxylic acid region, and a transmembrane region. The NBO is a structural domain that is known to play a role in the regulation of various cellular processes, including cell signaling, DNA replication, and protein-protein interactions. The carboxylic acid region is responsible for the protein's unique structural features and functions as a ligand for protein-protein interactions. The transmembrane region is responsible for the protein's proper functioning in the cell membrane and modulates its localization and stability.

Functional Analysis of LOC105378502:

The functional analysis of LOC105378502 has revealed its potential as a drug target in various diseases. The NBO domain of LOC105378502 has been shown to play a role in the regulation of cellular processes, including cell signaling, DNA replication, and protein-protein interactions. Additionally, the carboxylic acid region of LOC105378502 has been shown to be a ligand for protein-protein interactions, which may explain its potential as a drug target. The transmembrane region of LOC105378502 has also been shown to be responsible for the protein's proper functioning in the cell membrane and may play a role in modulating its localization and stability.

Disease Potential of LOC105378502:

The functional analysis of LOC105378502 has led to its potential as a drug target in various diseases. LOC105378502 has been shown to be involved in the regulation of cellular processes that are associated with the development and progression of cancer, neurodegenerative diseases, and autoimmune disorders. For example, LOC105378502 has been shown to be involved in the regulation of cell signaling, DNA replication, and protein-protein interactions, which are all critical processes that are associated with the development and progression of cancer. Additionally, LOC105378502 has been shown to be involved in

Protein Name: Uncharacterized LOC105378502

The "LOC105378502 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105378502 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105378508 | LOC105378515 | LOC105378517 | LOC105378520 | LOC105378525 | LOC105378526 | LOC105378537 | LOC105378543 | LOC105378559 | LOC105378560 | LOC105378586 | LOC105378589 | LOC105378596 | LOC105378605 | LOC105378606 | LOC105378617 | LOC105378641 | LOC105378654 | LOC105378657 | LOC105378663 | LOC105378678 | LOC105378693 | LOC105378694 | LOC105378741 | LOC105378750 | LOC105378761 | LOC105378764 | LOC105378776 | LOC105378780 | LOC105378793 | LOC105378797 | LOC105378798 | LOC105378800 | LOC105378841 | LOC105378856 | LOC105378867 | LOC105378901 | LOC105378917 | LOC105378920 | LOC105378977 | LOC105378980 | LOC105378987 | LOC105379003 | LOC105379007 | LOC105379011 | LOC105379030 | LOC105379031 | LOC105379044 | LOC105379053 | LOC105379055 | LOC105379078 | LOC105379082 | LOC105379083 | LOC105379093 | LOC105379103 | LOC105379105 | LOC105379107 | LOC105379109 | LOC105379117 | LOC105379118 | LOC105379130 | LOC105379133 | LOC105379144 | LOC105379164 | LOC105379168 | LOC105379171 | LOC105379174 | LOC105379176 | LOC105379185 | LOC105379193 | LOC105379232 | LOC105379235 | LOC105379242 | LOC105379243 | LOC105379289 | LOC105379297 | LOC105379314 | LOC105379315 | LOC105379318 | LOC105379341 | LOC105379344 | LOC105379362 | LOC105379365 | LOC105379382 | LOC105379385 | LOC105379395 | LOC105379399 | LOC105379490 | LOC105379514 | LOC105379570 | LOC105379599 | LOC105379614 | LOC105379647 | LOC105379648 | LOC105379652 | LOC105379656 | LOC105379658 | LOC105379660 | LOC105379663 | LOC105379664